Help with addiction starts with one call.

877-922-8999
Person Person Person

Thousands of people helped nationwide.

University of Maryland Medical Center - Methadone Program

Open Now
Contact Information
1001 West Pratt Street, Baltimore, MD, Maryland 21223
0.000
Detailed Information

University of Maryland Medical Center Methadone Program

Located in the heart of Baltimore, Maryland, the University of Maryland Medical Center (UMMC) Methadone Program provides vital medication-assisted treatment (MAT) for individuals struggling with opioid use disorder. This specialized clinic is committed to offering comprehensive, evidence-based care within a supportive and professional clinical environment. The program aims to help patients achieve stability, reduce illicit opioid use, minimize associated health risks, and improve overall quality of life.

Comprehensive Treatment Services

The UMMC Methadone Program focuses on delivering integrated care where medication is combined with essential behavioral therapies and support services. Methadone is administered daily under the supervision of medical staff to help mitigate withdrawal symptoms and curb cravings, providing patients with the foundation needed to engage in recovery. Treatment plans are highly individualized, ensuring that each patient receives care tailored to their specific needs and circumstances.

Key Components of Care

  • Medication-Assisted Treatment (MAT) utilizing Methadone
  • Individual and group counseling sessions
  • Case management services
  • Referrals for additional medical and mental health care
  • Regular drug screening and monitoring

A Path to Stability in Baltimore

As part of the renowned University of Maryland Medical Center system, this methadone clinic adheres to the highest standards of medical practice and patient confidentiality. Their dedicated team of physicians, nurses, and counselors works collaboratively to manage the medical aspects of addiction while addressing the underlying psychological and social factors contributing to substance use. The program is conveniently situated at 1001 West Pratt Street, offering accessible care to residents throughout the Baltimore metropolitan area who are seeking reliable, long-term support in their journey toward recovery.

Frequently Asked Questions

Is methadone a permanent commitment?

No. While methadone is used for long-term stabilization, the goal of treatment is eventual stability. The duration of treatment varies greatly among individuals and is determined through ongoing consultation between the patient and the medical team.

Do I need an appointment for intake?

Prospective patients should contact the program directly at the University of Maryland Medical Center to inquire about current admission procedures, intake requirements, and scheduling availability.

Does this program offer other medications besides methadone?

This specific program focuses on methadone as its primary medication-assisted treatment option for opioid use disorder.

Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
Type of Care
Substance use treatment
Detoxification
Service Setting
Outpatient, Residential/24-hour residential, Intensive outpatient treatment, Regular outpatient treatment
Hospitals
General Hospital (including VA hospital)
Opioid Medications used in Treatment
Methadone used in Treatment, Buprenorphine used in Treatment, Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Other contracted prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification
Buprenorphine maintenance
Federally-certified Opioid Treatment Program
Methadone detoxification
Methadone maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram
Methadone
Buprenorphine with naloxone
Buprenorphine (extended-release, injectable)
Naltrexone (extended-release, injectable)
Medications for HIV treatment
Medications for Hepatitis C treatment
Medications for pre-exposure to prophylaxis
Medication for mental disorders
Nicotine replacement
Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management
Brief intervention
Cognitive behavioral therapy
Contingency management/motivational incentives
Motivational interviewing
Relapse prevention
Substance use disorder counseling
Trauma-related counseling
Telemedicine/telehealth therapy
12-step facilitation
Facility Operation
Private non-profit organization
License/Certification/Accreditation
State substance use treatment agency
State department of health
Commission on Accreditation of Rehabilitation Facilities (CARF)
Find Help (877) 922-8999